Ewa Wypasek Selected Research

procollagen type I carboxy terminal peptide (PICP)

1/2020	Kinetics of selected serum markers of fibrosis in patients with dilated cardiomyopathy and different grades of diastolic dysfunction of the left ventricle.
6/2017	Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR.
1/2017	12-month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new-onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis.
12/2016	Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ewa Wypasek Research Topics

Disease

9	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 10/2011
9	Fibrosis (Cirrhosis) 03/2021 - 12/2016
8	Thrombophilia 01/2022 - 12/2009
8	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2021 - 12/2016
7	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 04/2019 - 01/2014
6	Venous Thromboembolism 01/2022 - 06/2015
6	Protein S Deficiency (Deficiency, Protein S) 01/2021 - 07/2013
5	Venous Thrombosis (Deep-Vein Thrombosis) 04/2022 - 12/2009
5	Inflammation (Inflammations) 07/2014 - 01/2010
4	Hemorrhage 10/2019 - 03/2013
4	Neoplasms (Cancer) 06/2017 - 01/2016
3	Atherosclerosis 11/2014 - 10/2011
3	Coronary Artery Disease (Coronary Atherosclerosis) 07/2014 - 08/2009
3	Peritonitis 10/2012 - 12/2004
2	Ischemic Stroke 01/2022 - 12/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 07/2011
2	Heart Failure 11/2020 - 01/2016
2	Atherosclerotic Plaque (Atheroma) 01/2020 - 12/2012
2	Thrombosis (Thrombus) 01/2016 - 12/2009
1	Pulmonary Embolism 04/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Thromboembolism 10/2021
1	Afibrinogenemia (Fibrinogen Deficiency) 01/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Hypersensitivity (Allergy) 12/2020
1	Atopic Dermatitis (Atopic Eczema) 12/2020
1	Stroke (Strokes) 01/2020
1	Peripheral Arterial Disease 01/2020
1	Ischemia 01/2020
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2019
1	MINOCA 01/2019
1	Menorrhagia 01/2019
1	Atrial Fibrillation 07/2018
1	Abdominal Aortic Aneurysm 05/2018
1	Migraine Disorders (Migraine) 01/2018
1	Bicuspid Aortic Valve Disease 06/2017

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 03/2021 - 07/2011
8	FibrinIBA 04/2022 - 08/2009
7	AntithrombinsIBA 01/2020 - 08/2011
6	Protein CIBA 01/2022 - 07/2013
5	Factor XIII (Coagulation Factor XIII)IBA 04/2022 - 08/2009
5	Fibrinogen (Factor I)FDA Link 04/2022 - 12/2009
5	AnticoagulantsIBA 01/2021 - 03/2013
5	RivaroxabanIBA 01/2020 - 07/2014
5	factor V LeidenIBA 04/2019 - 12/2009
4	CollagenIBA 03/2021 - 12/2016
4	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2020 - 12/2016
4	Connective Tissue Growth FactorIBA 01/2020 - 12/2016
4	Vitamin K FDA Link 01/2020 - 03/2013
4	procollagen type I carboxy terminal peptide (PICP)IBA 01/2020 - 12/2016
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2005
3	Collagen Type I (Type I Collagen)IBA 01/2020 - 12/2016
3	Prothrombin (Factor II)IBA 04/2019 - 08/2011
3	Peptides (Polypeptides)IBA 06/2017 - 12/2016
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2017 - 12/2016
3	C-Reactive ProteinIBA 01/2016 - 07/2014
3	ZymosanIBA 10/2012 - 12/2004
3	Morphine (MS Contin)FDA LinkGeneric 10/2012 - 12/2004
2	Lipoprotein(a)IBA 01/2022 - 01/2019
2	Galectin 3 (LGALS3)IBA 03/2021 - 01/2020
2	Immunoglobulin E (IgE)IBA 12/2020 - 12/2020
2	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2020 - 10/2012
2	Oral ContraceptivesIBA 09/2020 - 12/2009
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 01/2017
2	Factor VIII (Coagulation Factor VIII)IBA 01/2020 - 01/2019
2	Dabigatran FDA Link 01/2020 - 01/2019
2	Protein SIBA 01/2019 - 09/2015
2	MicroRNAs (MicroRNA)IBA 01/2018 - 03/2017
2	Cytochrome P-450 CYP2C9IBA 01/2018 - 03/2013
2	Matrix Metalloproteinases (MMPs)IBA 06/2017 - 12/2016
2	Thrombin FDA Link 06/2015 - 08/2011
2	CytokinesIBA 10/2012 - 01/2010
1	AldosteroneIBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	CatecholaminesIBA 01/2022
1	LipidsIBA 01/2022
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2022
1	Trinitrotoluene (TNT)IBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	Troponin T (Troponin T1)IBA 01/2021
1	GadoliniumIBA 01/2021
1	IgE Receptors (Fc epsilon RI)IBA 12/2020
1	Neprilysin (Neutral Endopeptidase)IBA 11/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2020
1	RNA Splice SitesIBA 09/2020
1	Plasminogen Activator Inhibitor 1IBA 01/2020
1	HomocysteineIBA 01/2019
1	AcenocoumarolIBA 07/2018
1	alpha-2-Antiplasmin (alpha 2 Antiplasmin)IBA 05/2018
1	Orexin ReceptorsIBA 01/2018
1	3' Untranslated Regions (3' UTR)IBA 01/2018
1	Serotonin (5 Hydroxytryptamine)IBA 01/2018
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2018
1	OrexinsIBA 01/2018
1	Biological ProductsIBA 06/2017
1	Collagen Type III (Type III Collagen)IBA 12/2016
1	EnzymesIBA 12/2016

Therapy/Procedure

5	Therapeutics 06/2015 - 12/2009
1	Artificial Heart (Artificial Hearts) 07/2018